KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Common Equity (2016 - 2025)

Historic Common Equity for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $18.6 billion.

  • Bristol Myers Squibb's Common Equity rose 813.95% to $18.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 billion, marking a year-over-year increase of 813.95%. This contributed to the annual value of $16.4 billion for FY2024, which is 4441.92% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Common Equity of $18.6 billion as of Q3 2025, which was up 813.95% from $17.5 billion recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Common Equity high stood at $45.2 billion for Q4 2022, and its period low was $16.4 billion during Q4 2024.
  • Its 5-year average for Common Equity is $28.5 billion, with a median of $31.6 billion in 2022.
  • Per our database at Business Quant, Bristol Myers Squibb's Common Equity plummeted by 4810.26% in 2024 and then skyrocketed by 813.95% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Common Equity (Quarter) stood at $44.4 billion in 2021, then grew by 1.81% to $45.2 billion in 2022, then plummeted by 34.72% to $29.5 billion in 2023, then plummeted by 44.42% to $16.4 billion in 2024, then rose by 13.5% to $18.6 billion in 2025.
  • Its Common Equity was $18.6 billion in Q3 2025, compared to $17.5 billion in Q2 2025 and $17.4 billion in Q1 2025.